SK Biopharmaceuticals. (326030.KQ) Q3 2024 Earnings

8AugConfirmed
Aug 22
Q4 2023
Q2 2024
Q3 2024
-579.77
-282.91
13.95
310.81

Details

Expected EPS
106.28287871040001
Actual EPS
310.8110182056
Surprise EPS
204.53
Surprise Percent
+192.44%

Description

SK Biopharmaceuticals. (326030.KQ) has reported earnings of 310.8110182056 per share for Q3 2024.

0 Comments

Share your thoughts